SCHEMBL10022096

SCHEMBL10022096

C=Cc1ccccc1-c1cccc(-c2ccncc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.45
PIK3CA P42336 1/20 0.42
PRKCI P41743 1/20 0.41
KIF11 P52732 1/20 0.41
PRKDC P78527 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
IMPDH2 P12268 1/20 0.38
CYP19A1 P11511 1/20 0.37
CYP11B2 P19099 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
MKNK1 Q9BUB5 1/20 0.36
PDK2 Q15119 1/20 0.36
PRKACA P17612 2/20 0.36
CDK2 P24941 2/20 0.36
GSK3B P49841 2/20 0.36
ERN1 O75460 1/20 0.36
AURKA O14965 1/20 0.36
CDK1 P06493 1/20 0.36
LYN P07948 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8759090 0.88 PTGER1 (0.41) LMNAMAPTC1S
SCHEMBL10022120 0.86 NOTUM (0.46) NOTUMPIK3CAKIF11IMPDH2CYP19A1
SCHEMBL1878224 0.86 NOTUM (0.44) NOTUMPIK3CAIMPDH2CYP19A1CYP11B2
SCHEMBL2463846 0.86 ALDH1A1 (0.43) C1S
SCHEMBL10022104 0.84 MEN1 (0.47) PIK3CAPRMT6CYP19A1CYP11B2MKNK1
SCHEMBL10022105 0.79 CYP19A1 (0.46) NOTUMPIK3CAIMPDH2CYP19A1CYP11B2
SCHEMBL13203239 0.78 NOTUM (0.62) NOTUMPIK3CAPRKCIKIF11PRMT6
SCHEMBL5632912 0.78 GRM5 (0.45) PIK3CAPRKDCLMNAPDK2
SCHEMBL30525464 0.76 PTGER1 (0.38) PRKDCLMNAMAPTC1S
Biphenyl SCHEMBL28948287 0.76 ALDH1A1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110642-B2 Synthesis of vinylphenylpyridine and living anionic polymerization GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-02-07 US disclosed
US-8110642-B2 Synthesis of vinylphenylpyridine and living anionic polymerization GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2012-02-07 US disclosed
US-20090105416-A1 Synthesis of Vinylphenylpyridine and Living Anionic Polymerization GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-04-23 US disclosed
US-20090105416-A1 Synthesis of Vinylphenylpyridine and Living Anionic Polymerization GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2009-04-23 US disclosed
WO-2007129810-A1 SYNTHESIS OF VINYLPHENYLPYRIDINE AND LIVING ANIONIC POLYMERIZATION GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2007-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105416-A1 Synthesis of Vinylphenylpyridine and Living Anionic Polymerization PBRM1, MVD, PCBP1 NOTUM 1094/4885PIK3CA 977/4885PRKCI 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.